Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab
Background Psoriasis, psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) are chronic inflammatory diseases that often affect women of childbearing age. Detailed information about pregnancy and related outcomes across these indications in patients exposed to ixekizumab is lacking.Objective...
Saved in:
Main Authors: | A. Egeberg, L. Iversen, A. B. Kimball, S. Kelly, E. Grace, H. Patel, W. Xu, G. Gallo, E. Riedl, S. R. Feldman |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-07-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2021.1976375 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Salivary Levels of Interleukin-17 in Iranian Patients With Systemic Sclerosis
by: Ali Tadayon, et al.
Published: (2024-12-01) -
South African Rheumatism and Arthritis Association 2024 guidelines for the management of axial spondyloarthritis
by: A B Maharaj, et al.
Published: (2024-10-01) -
Influence of sacroiliac joint variation on clinical features of axial spondyloarthritis: a comparative analysis
by: Denis Poddubnyy, et al.
Published: (2025-02-01) -
Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study
by: Yoshiki Okada, et al.
Published: (2025-02-01) -
Efficacy and safety of Janus kinase inhibitors in the treatment of psoriasis and psoriatic arthritis: An analysis of evidence from 2014 to 2022
by: Jiao Wang, et al.
Published: (2025-02-01)